Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug
Dec. 7, 2017
| By Diane Mapes / Fred Hutch News Service
Results from a large multicenter trial released Thursday at the San Antonio Breast Cancer Symposium offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.
Study to examine how integrative medicine affects breast cancer outcomes
Aug. 2, 2010
The Fred Hutchinson Cancer Research Center and Bastyr University, a natural health sciences institution in Kenmore, Wash., received a joint $3.1 million grant for the study of complementary and integrative care for breast cancer from the National Institutes of Health and the National Center for Complementary and Alternative Medicine.